Neuronal actions of glucocorticoids: Focus on depression

Journal of Steroid Biochemistry and Molecular Biology

Volumn 108, Issue 3-5, 2008, Pages 300-309

  Yu, Shuang ^a   Holsboer, Florian ^a   Almeida, Osborne F X ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Apoptosis; Depression; Glucocorticoids; Hypothalamo pituitary adrenal axis; Mutant mice; Neuritic atrophy; Neurogenesis; Stress; Transgenic mice

Indexed keywords

ALDOSTERONE; ANTIDEPRESSANT AGENT; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR;

APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CELL DEATH; CELL SURVIVAL; CORTICOSTEROID RELEASE; CUSHING SYNDROME; DEPRESSION; DISEASE ASSOCIATION; GENETIC MODEL; HIPPOCAMPUS; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS ADRENAL SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOGENESIS;

ANIMALS; APOPTOSIS; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; HIPPOCAMPUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; NEURONAL PLASTICITY; NEURONS; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

MUS; MUS MUSCULUS;

EID: 38749146837     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.09.014     Document Type: Article

References (103)

1. de Kloet E.R., Sibug R.M., Helmerhorst F.M., and Schmidt M.V. Stress, genes and the mechanism of programming the brain for later life. Neurosci. Biobehav. Rev. 29 (2005) 271-281
2. DeBattista C., and Belanoff J. The use of mifepristone in the treatment of neuropsychiatric disorders. Trends Endocrinol. Metab. 17 (2006) 117-121
3. Gold P.W., and Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol. Psychiatry 7 (2002) 254-275
4. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (1999) 477-501
5. Brady L.S., Whitfield Jr. H.J., Fox R.J., Gold P.W., and Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J. Clin. Invest. 87 (1991) 831-837
6. Keck M.E., Ohl F., Holsboer F., and Muller M.B. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci. Biobehav. Rev. (2005) 867-889
7. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., and Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19 (1998) 162-166
8. Sillaber I., Rammes G., Zimmermann S., Mahal B., Zieglgansberger W., Wurst W., Holsboer F., and Spanagel R. Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 296 (2002) 931-933
9. Zobel A.W., Nickel T., Kunzel H.E., Ackl N., Sonntag A., Ising M., and Holsboer F. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J. Psychiatry Res. 34 (2000) 171-181
10. Chen Y., Bender R.A., Brunson K.L., Pomper J.K., Grigoriadis D.E., Wurst W., and Baram T.Z. Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15782-15787
11. Sousa N., and Almeida O.F.X. Corticosteroids: sculptors of the hippocampal formation. Rev. Neurosci. 13 (2002) 59-84
12. Cerqueira J.J., Taipa R., Uylings H.B., Almeida O.F., and Sousa N. Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing rorticosteroid regimens. Cereb. Cortex (2006) (Epub ahead of print)
13. Alonso R., Griebel G., Pavone G., Stemmelin J., Le Fur G., and Soubrie P. Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Mol. Psychiatry 9 (2004) pp. 278-286, 224
14. Kellendonk C., Gass P., Kretz O., Schutz G., and Tronche F. Corticosteroid receptors in the brain: gene targeting studies. Brain Res. Bull. 57 (2002) 73-78
15. Pepin M.C., Pothier F., and Barden N. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol. Pharmacol. 42 (1992) 991-995
16. Marchetti B., Morale M.C., Testa N., Tirolo C., Caniglia S., Amor S., Dijkstra C.D., and Barden N. Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA. Brain Res. Brain Res. Rev. 37 (2001) 259-272
17. Wei Q., Lu X.Y., Liu L., Schafer G., Shieh K.R., Burke S., Robinson T.E., Watson S.J., Seasholtz A.F., and Akil H. Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 11851-11856
18. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., and Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23 (1999) 99-103
19. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., and Muglia L.J. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Acad. Natl. Sci. U.S.A. 102 (2005) 473-478
20. Voegel J.J., Heine M.J., Zechel C., Chambon P., and Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15 (1996) 3667-3675
21. Patchev A.V., Fischer D., Wolf S.S., Herkenham M., Gotz F., Gehin M., Chambon P., Patchev V.K., and Almeida O.F.X. Insidious adrenocortical insufficiency underlies neuroendocrine dysregulation in TIF-2 deficient mice. FASEB J. (2006) (Epub ahead of print)
22. Gehin M., Mark M., Dennefeld C., Dierich A., Gronemeyer H., and Chambon P. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell Biol. 22 (2002) 5923-5937
23. + metabolism. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 9424-9429
24. Gass P., Kretz O., Wolfer D.P., Berger S., Tronche F., Reichardt H.M., Kellendonk C., Lipp H.P., Schmid W., and Schutz G. Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep. 1 (2000) 447-451
25. Berger S., Wolfer D.P., Selbach O., Alter H., Erdmann G., Reichardt H.M., Chepkova A.N., Welzl H., Haas H.L., Lipp H.P., and Schutz G. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 195-200
26. Usuku T., Nishi M., Morimoto M., Brewer J.A., Muglia L.J., Sugimoto T., and Kawata M. Visualization of glucocorticoid receptor in the brain of green fluorescent protein-glucocorticoid receptor knockin mice. Neuroscience 135 (2005) 1119-1128
27. Sapolsky R.M., Krey L.C., and McEwen B.S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7 (1986) 284-301
28. Lucassen P.J., Fuchs E., and Czeh B. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol. Psychiatry 55 (2004) 789-796
29. Harlan J., Chen Y., Gubbins E., Mueller R., Roch J.M., Walter K., Lake M., Olsen T., Metzger P., Dorwin S., Ladror U., Egan D.A., Severin J., Johnson R.W., Holzman T.F., Voelp K., Davenport C., Beck A., Potter J., Gopalakrishnan M., Hahn A., Spear B.B., Halbert D.N., Sullivan J.P., Abkevich V., Neff C.D., Skolnick M.H., Shattuck D., and Katz D.A. Variants in Apaf-1 segregating with major depression promote apoptosome function. Mol. Psychiatry 11 (2006) 76-85
30. Starkman M.N., Gebarski S.S., Berent S., and Schteingart D.E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol. Psychiatry 32 (1992) 756-765
31. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3908-3913
32. Lupien S.J., Nair N.P., Briere S., Maheu F., Tu M.T., Lemay M., McEwen B.S., and Meaney M.J. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev. Neurosci. 10 (1999) 117-139
33. Watanabe Y., Gould E., and McEwen B.S. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res. 588 (1992) 341-345
34. Uno H., Tarara R., Else J.G., Suleman M.A., and Sapolsky R.M. Hippocampal damage associated with prolonged and fatal stress in primates. J. Neurosci. 9 (1989) 1705-1711
35. Woolley C.S., Gould E., and McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531 (1990) 225-231
36. Sapolsky R.M., Uno H., Rebert C.S., and Finch C.E. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J. Neurosci. 10 (1990) 2897-2902
37. Radley J.J., and Morrison J.H. Repeated stress and structural plasticity in the brain. Ageing Res. Rev. 4 (2005) 271-287
38. Cerqueira J.J., Pego J.M., Taipa R., Bessa J.M., Almeida O.F., and Sousa N. Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J. Neurosci. 25 (2005) 7792-7800
39. Cerqueira J.J., Catania C., Sotiropoulos I., Schubert M., Kalisch R., Almeida O.F.X., Auer D.P., and Sousa N. Corticosteroid status influences the volume of the rat cingulate cortex-a magnetic resonance imaging study. J. Psychiatry Res. 39 (2005) 451-460
40. Tirard M., Jasbinsek J., Almeida O.F.X., and Michaelidis T.M. The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells. J. Mol. Endocrinol. 32 (2004) 825-841
41. Obradovic D., Tirard M., Nemethy Z., Hirsch O., Gronemeyer H., and Almeida O.F.X. DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors?. Mol. Pharmacol. 65 (2004) 761-769
42. Almeida O.F.X., Conde G.L., Crochemore C., Demeneix B.A., Fischer D., Hassan A.H., Meyer M., Holsboer F., and Michaelidis T.M. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 14 (2000) 779-790
43. Sousa N., Paula-Barbosa M.M., and Almeida O.F.X. Ligand and subfield specificity of corticoid-induced neuronal loss in the rat hippocampal formation. Neuroscience 89 (1999) 1079-1087
44. Woolley C.S., Gould E., Sakai R.R., Spencer R.L., and McEwen B.S. Effects of aldosterone or RU28362 treatment on adrenalectomy-induced cell death in the dentate gyrus of the adult rat. Brain Res. 554 (1991) 312-315
45. Sloviter R.S., Sollas A.L., and Neubort S. Hippocampal dentate granule cell degeneration after adrenalectomy in the rat is not reversed by dexamethasone. Brain Res. 682 (1995) 227-230
46. Sousa N., Madeira M.D., and Paula-Barbosa M.M. Corticosterone replacement restores normal morphological features to the hippocampal dendrites, axons and synapses of adrenalectomized rats. J. Neurocytol. 28 (1999) 541-558
47. Hassan A.H., von Rosenstiel P., Patchev V.K., Holsboer F., and Almeida O.F.X. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp. Neurol. 140 (1996) 43-52
48. Lu J., Nemethy Zs., Pego J.M., Cerqueira J.J., Sousa N., and Almeida O.F.X. The cellular biology of the stress response. In: Steckler T., Kalin N., and Reul J.M.H.M. (Eds). Handbook of Stress and the Brain vol. 15 (2005), Elsevier, Amsterdam 729-749
49. de Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19 (1998) 269-301
50. Stein-Behrens B.A., Lin W.J., and Sapolsky R.M. Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus. J. Neurochem. 63 (1994) 596-602
51. Behl C., Lezoualc'h F., Trapp T., Widmann M., Skutella T., and Holsboer F. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138 (1997) 101-106
52. Crochemore C., Lu J., Wu Y., Liposits Z., Sousa N., Holsboer F., and Almeida O.F.X. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol. Psychiatry 10 (2005) 790-798
53. Muller M.B., Keck M.E., Binder E.B., Kresse A.E., Hagemeyer T.P., Landgraf R., Holsboer F., and Uhr M. ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 28 (2003) 1991-1999
54. Hassan A.H., Patchev V.K., von Rosenstiel P., Holsboer F., and Almeida O.F. Plasticity of hippocampal corticosteroid receptors during aging in the rat. FASEB J. 13 (1999) 115-122
55. Reul J.M., Stec I., Soder M., and Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133 (1993) 312-320
56. Oltvai Z.N., Milliman C.L., and Korsmever S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
57. Zinkel S., Gross A., and Yang E. Bcl2 faimily in DNA damage and cell cycle control. Cell Death Differ. 13 (2006) 1351-1359
58. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
59. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks T., and Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377 (1995) 552-557
60. Waldman T., Kinzler K.W., and Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55 (1995) 5187-5190
61. Moll U.M., Wolff S., Speidel D., and Deppert W. Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 17 (2005) 631-636
62. Schreiber S.S., Sakhi S., Dugich-Djordjevic M.M., and Nichols N.R. Tumor suppressor p53 induction and DNA damage in hippocampal granule cells after adrenalectomy. Exp. Neurol. 130 (1994) 368-376
63. Crochemore C., Michaelidis T.M., Fischer D., Loeffler J.P., and Almeida O.F.X. Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation. FASEB J. 16 (2002) 761-770
64. Lu J., Goula D., Sousa N., and Almeida O.F.X. Ionotropic and metabotropic glutamate receptor mediation of glucocorticoid-induced apoptosis in hippocampal cells and the neuroprotective role of synaptic N-methyl-d-aspartate receptors. Neuroscience 121 (2003) 123-131
65. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K., Gray N.A., Zarate Jr. C.A., and Charney D.S. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 53 (2003) 707-742
66. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
67. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hortnagl H., Flor H., Henn F.A., Schutz G., and Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 25 (2005) 6243-6250
68. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59 (2006) 1116-1127
69. Yamada S., Yamamoto M., Ozawa H., Riederer P., and Saito T. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J. Neural Transm. 110 (2003) 671-680
70. Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 352 (1998) 1754-1755
71. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50 (2001) 260-265
72. Swaab D.F., Bao A.M., and Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 4 (2005) 141-194
73. Starkman M.N., Giordani B., Gebarski S.S., and Schteingart D.E. Improvement in learning associated with increase in hippocampal formation volume. Biol. Psychiatry 53 (2003) 233-238
74. Czeh B., Simon M., Schmelting B., Hiemke C., and Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31 (2006) 1616-1626
75. Flores B.H., Kenna H., Keller J., Solvason H.B., and Schatzberg A.F. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 31 (2006) 628-636
76. Altman J., and Das G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 124 (1965) 319-335
77. Cameron H.A., and McKay R.D. Restoring production of hippocampal neurons in old age. Nat. Neurosci. 2 (1999) 894-897
78. Song H., Kempermann G., Overstreet Wadiche L., Zhao C., Schinder A.F., and Bischofberger J. New neurons in the adult mammalian brain: synaptogenesis and functional integration. J. Neurosci. 25 (2005) 10366-10368
79. Garcia A., Steiner B., Kronenberg G., Bick-Sander A., and Kempermann G. Age-dependent expression of glucocorticoid- and mineralocorticoid receptors on neural precursor cell populations in the adult murine hippocampus. Aging Cell 3 (2004) 363-371
80. Gould E., Tanapat P., McEwen B.S., Flugge G., and Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3168-3171
81. Sapolsky R.M. Is impaired neurogenesis relevant to the affective symptoms of depression?. Biol. Psychiatry 56 (2004) 137-139
82. Fuchs E., Flugge G., and Czeh B. Remodeling of neuronal networks by stress. Front. Biosci. 11 (2006) 2746-2758
83. Cameron H.A., and Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 61 (1994) 203-209
84. Kim J.B., Ju J.Y., Kim J.H., Kim T.Y., Yang B.H., Lee Y.S., and Son H. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro. Brain Res. 1027 (2004) 1-10
85. Gould E., Cameron H.A., Daniels D.C., Woolley C.S., and McEwen B.S. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J. Neurosci. 12 (1992) 3642-3650
86. Wong E.Y., and Herbert J. Roles of mineralocorticoid and glucocorticoid receptors in the regulation of progenitor proliferation in the adult hippocampus. Eur. J. Neurosci. 22 (2005) 785-792
87. Fischer A.K., von Rosenstiel P., Fuchs E., Goula D., Almeida O.F.X., and Czeh B. The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat. Brain Res. 947 (2002) 290-293
88. Wong E.Y., and Herbert J. Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus. Neuroscience 137 (2006) 83-92
89. Vollmayr B., Simonis C., Weber S., Gass P., and Henn F. Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol. Psychiatry 54 (2003) 1035-1040
90. Malberg J.E., and Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28 (2003) 1562-1571
91. Heine V.M., Maslam S., Zareno J., Joels M., and Lucassen P.J. Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. Eur. J. Neurosci. 19 (2004) 131-144
92. Sundberg M., Savola S., Hienola A., Korhonen L., and Lindholm D. Glucocorticoid hormones decrease proliferation of embryonic neural stem cells through ubiquitin-mediated degradation of cyclin D1. J. Neurosci. 26 (2006) 5402-5410
93. Rakic P. Neurogenesis in adult primate neocortex: an evaluation of the evidence. Nat. Rev. Neurosci. 3 (2002) 65-71
94. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., and Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 410 (2001) 372-376
95. Duman R.S. Depression: a case of neuronal life and death?. Biol. Psychiatry 56 (2004) 140-145
96. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
97. Laplagne D.A., Esposito M.S., Piatti V.C., Morgenstern N.A., Zhao C., van Praag H., Gage F.H., and Schinder A.F. Functional convergence of neurons generated in the developing and adult hippocampus. PLoS Biol. 4 (2006) e409
98. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., and Drevets W.C. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 64 (2007) 193-200
99. Herman J.P., and Larson B.R. Differential regulation of forebrain glutamic acid decarboxylase mRNA expression by aging and stress. Brain Res. 912 (2001) 60-66
100. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48 (2000) 766-777
101. Bowley M.P., Drevets W.C., Ongur D., and Price J.L. Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry 52 (2002) 404-412
102. Crossin K.L., Tai M.H., Krushel L.A., Mauro V.P., and Edelman G.M. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2687-2692
103. Wennstrom M., Hellsten J., Ekstrand J., Lindgren H., and Tingstrom A. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol. Psychiatry 59 (2006) 178-186